Go to content
Crucell N.V.

Crucell N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 11 nov 2008 - 08:11
Statutaire naam Crucell N.V.
Titel Crucell Announces Third Quarter 2008 Results
Bericht Crucell Achieves Profitability in Q3 2008 Crucell announces third quarter 2008 results with net income of €12.3 million. Total revenue and other operating income increased by 31% to €82.1 million compared to the same quarter last year. Gross margin in the third quarter improved to 50% (from 36% last year). 2008 full year guidance for total revenue and other operating income growth increased to 25-30% in constant currencies (from 20%). Leiden, The Netherlands (November 11, 2008) – Dutch biopharma company Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) today announced its financial results for the third quarter of 2008, based on International Financial Reporting Standards (IFRS). These financial results are unaudited.